Additional procodes: mnh, mni, kwp, kwp.Reporter is a company representative.The device was received, the investigation is in progress, no conclusion could be drawn at the time of filing this report.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.H10 additional narrative h3, h6: investigation summary investigation flow: damage visual inspection; snap-on transverse connector l30-33 f/r (part.No: 04.633.330, lot.No: 6373108, qty: 1) was returned and received at us cq.The device was received in disassembled condition.Upon visual inspection at cq, it is observed that there were few scratched and nicked spots on the surface of the subcomponent c channel of the device.The device is missing subcomponents like compression camp and spring washer.Most distal thread of the actuation screw of the device got stripped.Thus, the complaint is being confirmed.Device failure/defect identified? yes document/specification review no design issues or discrepancies were noticed.Complaint confirmed? yes investigation conclusion the complaint condition was confirmed for the snap-on transverse connector l30-33 f/r (part.No: 04.633.330, lot.No: 6373108).No definitive root cause cannot be determined for the reported condition.It is possible that the device might have encountered unintended forces.During the investigation, no product design issues, or discrepancies were observed that may have contributed to the complaint condition.Based upon these results, no corrective and/or preventative action is proposed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.Therefore, it has been determined that no corrective and/or preventive action is proposed.Device history lot part number: 04.633.330 lot number: 6373108 part manufacturing date: april 21, 2010 manufacturing site: elmira part expiration date: n/a nonconformance noted: us1031256; no impact on complaint condition.A review of the device history record revealed no complaint related anomalies.The device history record shows lot 6373108 of ti snap-on transconnectors was processed through the normal manufacturing and inspection operations with no rework or non conformances noted.This lot met all dimensional and visual criteria at the time of manufacture with no issues documented during the manufacture that would contribute to this complaint condition.A review of the component device history record(s) determined the component lots 6321608, 6341550, 6262777, 6341969, 6283239, 6284309, 6363963, 6350176, 6353251, 6237331, 6360205, 6243122, 6310713, 6331592, and 6333533 met all specifications with no issues documented that would contribute to this complaint condition.Ncr us1031256 was written for cosmetic marks on component lot 6262777.This nonconformance has no impact on the complaint condition, as all affected parts were reworked to correct the visual marks.A review of the raw material device history record(s) determined the raw material lots 6066985 and 6238480 met all specifications with no issues documented that would contribute to this complaint condition.Device history review a review of the device history record revealed no complaint related anomalies.This lot met all dimensional and visual criteria at the time of manufacture with no issues documented during the manufacture that would contribute to this complaint condition.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|